In clinical trials, hair loss was reported by roughly 5% of people taking tirzepatide (across 5mg–15mg doses), compared with about 1% in placebo groups. The gap is real, but the cause is not the drug acting directly on your follicles. The shedding is almost always telogen effluvium — a temporary shift in the hair growth cycle triggered by rapid weight loss and the nutritional stress that comes with it. Most people on Mounjaro never experience it, and for those who do, it typically reverses once weight stabilises and nutrition improves.
- Rapid weight loss pushing hair follicles prematurely into the resting (telogen) phase
- Reduced calorie and protein intake from Mounjaro's appetite-suppressing effects
- Shortfalls in zinc, iron and B vitamins, which support hair follicle maintenance
- Hormonal and metabolic shifts during active weight loss
Why does Mounjaro cause hair loss?
The short answer: Mounjaro suppresses appetite so effectively that many people unintentionally under-eat, and that caloric and nutritional shortfall is what stresses the hair follicle — not the tirzepatide molecule itself.
Hair grows in three phases: anagen (active growth, lasting years), catagen (a brief transition) and telogen (rest and shedding, lasting roughly three months). Normally around 85–90% of scalp hairs are in the anagen phase at any time. When the body experiences a significant physical stressor — such as losing weight rapidly — it can prematurely push a large proportion of follicles into telogen. Several months later, those hairs shed together. This is telogen effluvium, and it is the dominant mechanism behind hair thinning on GLP-1 medicines.
Three nutritional gaps compound the problem: insufficient calories restrict the energy available to follicles; low protein intake limits keratin synthesis (the structural protein hair is made from); and micronutrient shortfalls in zinc, iron and B vitamins deplete faster when overall food intake drops. Hormonal changes during weight loss can also play a role, particularly in women.
A practical timing clue: telogen effluvium typically appears about three months after the triggering event, so noting when the extra shedding started helps you and your GP identify the likely cause.
How common is it?
Trial data puts reported hair loss at roughly 5% of people on tirzepatide versus about 1% on placebo — meaning the clear majority of people on Mounjaro do not experience noticeable shedding.
Women report hair loss more often than men in weight-loss trials, likely reflecting hormonal sensitivity and the fact that changes in hair volume are more noticeable with longer hair. The shedding is generally temporary: it tends to begin around three months after rapid weight loss starts, continue for several months, and settle within 6–12 months once weight stabilises.
How to reduce the risk
The most effective approach is to protect your nutritional status from the start, before shedding becomes noticeable. None of this is medical advice — agree any supplementation or diet change with your GP or pharmacist.
- Prioritise protein at every meal. A common general guide is 0.8–1g of protein per kilogram of body weight daily. Chicken, eggs, Greek yoghurt, lentils and cottage cheese work well even with a reduced appetite — and eating the protein first means appetite suppression mid-meal costs you the chips, not the amino acids.
- Watch key micronutrients. Iron, zinc and B vitamins are the most commonly depleted during calorie restriction. Blood tests from your GP give a clearer picture than guessing.
- Go easy on styling. Heat tools, tight ponytails and chemical treatments add mechanical stress to already fragile strands.
- Track it. Logging shedding alongside your doses and weight gives your prescriber concrete data — the free printable tracker keeps it all in one place for your next appointment.
- Aim for steady, not dramatic, weight loss. Losing weight gradually is far less disruptive to the hair cycle. If your current dose is driving very fast loss, that's a conversation for your prescriber — the titration planner can help map gentler steps to discuss.
When to see a doctor
Telogen effluvium from weight loss is self-limiting for most people, but not every pattern of hair loss fits that description. See a GP (or ask for a dermatology referral) if you notice any of the following:
- Patchy or circular bald spots — may indicate alopecia areata rather than diffuse shedding
- Scalp itching, redness or inflammation — points to a skin condition needing its own treatment
- Shedding that continues beyond six months after your weight has stabilised
- Extreme fatigue, brittle nails or feeling unusually cold — can signal thyroid problems or iron-deficiency anaemia
The bottom line
Hair loss is not a routine reason to stop Mounjaro — that decision belongs with your prescriber, weighing the benefits of treatment against side effects. Useful questions for your appointment: "Can we check my thyroid, iron and ferritin levels?", "Is my rate of weight loss contributing, and should we adjust the plan?", and "Would a dietitian referral help me hit protein targets?". Ruling out other causes first leads to better outcomes.